Evidence map›Paper›PMID 35675801›Full record

ArticleCytogenetic and genome research2022

Genomic Features of Interstitial Deletions of Chromosome 9q in Acute Myeloid Leukemia.

Zhongxia Qi, Kwun Wah Wen, Anita Ki, Sonam Prakash, Scott Kogan, Jingwei Yu

Open access · hybridAbstract readNews
In one paragraph

Article in Cytogenetic and genome research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Chromosomal Damage, Chromosome Instability, and Polymorphisms inInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zhongxia QiDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA, Zhongxia.Qi@ucsf.edu.
Kwun Wah WenDepartment of Pathology, University of California San Francisco, San Francisco, California, USA.
Anita KiClinical Cytogenetics Laboratory, University of California San Francisco Medical Center, San Francisco, California, USA.
Sonam PrakashDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Scott KoganDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Jingwei YuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
University of California, San Francisco · USUniversity of California San Francisco Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial deletion in the long arm of chromosome 9 [del(9q)] is a fairly common cytogenetic finding associated with acute myeloid leukemia (AML), seen in approximately 2-5% of AML patients. However, the genomic features of the deletion remain largely unknown. Using chromosome analysis, single nucleotide polymorphism microarray, and next-generation sequencing, we characterized del(9q)s and other genomic alterations in 9 AML patients. We found several distinct features of the del(9q)s. The proximal breakpoints of the deletions are clustered within a 2.5-Mb region (chr9: 68,513,625-70,984,372; GRCh37) enriched with segmental duplications, which may represent a "hotspot" for genomic rearrangements. However, the distal breakpoints of the deletions vary significantly. In addition, the overall deleted region could be divided into a 14.4-Mb proximal constitutional region (chr9: 70,950,015-85,397,699; 9q21.11q21.32) and a 24.0-Mb distal oncogenic region (chr9: 85,397,700-109,427,261; 9q21.32q31.1). We further identified a 6.8-Mb common overlapped deletion region (CODR) in the distal region (chr9: 90,590,650-97,366,400). This CODR carries multiple genes that are reportedly involved in cancer pathogenesis. The prognostic value of the del(9q) in AML apparently depends on additional genomic alterations in the patients.

Indexed as

Chromosome DeletionLeukemia, Myeloid, AcuteChromosomesGenomicsHigh-Throughput Nucleotide SequencingHumansAcute myeloid leukemiaCancer-related genesCommon overlapped deletion regionDeletion of 9qGenomic analyses

Identifiers

PMID35675801
PMCPMC9677869
OpenAlexW4281694087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.